Physician profile
Timothy Mosher
NPI 1689081077
$5,824.06
in general payments reported to CMS, 2019-2025
40 companies · $723 in 2025
The $723 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,622 · 2022: $1,821 · 2023: $1,416 · 2024: $241 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,380.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $777.39 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $704.10 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $598.70 | 2021-2023 | Farxiga, Breztri, Fasenra |
| Lilly USA, LLC | $547.24 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $359.15 | 2021-2025 | Otezla, Evenity, Repatha |
| Corcept Therapeutics | $350.01 | 2023-2025 | Korlym |
| Pfizer INC. | $228.97 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $169.83 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $152.34 | 2021 | |
| Janssen Pharmaceuticals, INC | $140.61 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.35 | 2021-2022 | |
| Exact Sciences Corporation | $133.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medtronic, INC. | $130.40 | 2025 | Interstim |
| Dexcom, INC. | $127.82 | 2022-2025 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $118.72 | 2025 | Uzedy |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mosher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.